日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial

高剂量异烟肼对katG突变介导的异烟肼耐药结核病早期缺乏杀菌活性：一项随机II期临床试验

期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.202311-2004OC
Gausi, Kamunkhwala; Ignatius, Elisa H; De Jager, Veronique; Upton, Caryn; Kim, Soyeon; McKhann, Ashley; Moran, Laura; Wiesner, Lubbe; von Groote-Bidlingmaier, Florian; Marzinek, Philip; Vanker, Naadira; Yvetot, Joseph; Pierre, Samuel; Rosenkranz, Susan L; Swindells, Susan; Diacon, Andreas H; Nuermberger, Eric L; Denti, Paolo; Dooley, Kelly E
发表日期：2024
文献求助 收藏

A case series of forearm compartment syndrome complicating transradial cardiac catheterization

经桡动脉心脏导管插入术并发前臂筋膜室综合征的病例系列

期刊:Egyptian Heart Journal
影响因子:1.4
doi:10.1186/s43044-024-00498-y
Khirul Ashar, Nur Ayuni; Ismail, Imma Isniza; Lingam, Rahul; Mazlan, Naadira Faa'iza; Azmi, Nur Syahirah
发表日期：2024
文献求助 收藏

Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg(-1) rifampicin

利福平在 50 mg·kg(-1) 剂量下具有增强的杀菌活性，但耐受性差，属于剂量限制性不良反应。

期刊:European Respiratory Journal
影响因子:21
doi:10.1183/13993003.00955-2020
Te Brake, Lindsey H M; de Jager, Veronique; Narunsky, Kim; Vanker, Naadira; Svensson, Elin M; Phillips, Patrick P J; Gillespie, Stephen H; Heinrich, Norbert; Hoelscher, Michael; Dawson, Rodney; Diacon, Andreas H; Aarnoutse, Rob E; Boeree, Martin J
发表日期：2021
文献求助 收藏

Resistance-Conferring Mycobacterial Mutations and Quantification of Early Bactericidal Activity

分枝杆菌耐药性突变及早期杀菌活性的定量分析

期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.202007-2740LE
le Roux, Solomon P; Upton, Caryn; Vanker, Naadira; Dooley, Kelly E; Diacon, Andreas H
发表日期：2021
文献求助 收藏

A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial

高剂量异烟肼抗多重耐药结核病杀菌活性的半机制模型：一项随机临床试验的结果

期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.202103-0534OC
Gausi, Kamunkhwala; Ignatius, Elisa H; Sun, Xin; Kim, Soyeon; Moran, Laura; Wiesner, Lubbe; von Groote-Bidlingmaier, Florian; Hafner, Richard; Donahue, Kathleen; Vanker, Naadira; Rosenkranz, Susan L; Swindells, Susan; Diacon, Andreas H; Nuermberger, Eric L; Dooley, Kelly E; Denti, Paolo
发表日期：2021
文献求助 收藏

Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis

对接受治疗的结核病患者进行为期14天的PET/CT成像，以监测药物组合的活性

期刊:Science Translational Medicine
影响因子:14.6
doi:10.1126/scitranslmed.abd7618
Xie, Yingda L; de Jager, Veronique R; Chen, Ray Y; Dodd, Lori E; Paripati, Praveen; Via, Laura E; Follmann, Dean; Wang, Jing; Lumbard, Keith; Lahouar, Saher; Malherbe, Stephanus T; Andrews, Jenna; Yu, Xiang; Goldfeder, Lisa C; Cai, Ying; Arora, Kriti; Loxton, Andre G; Vanker, Naadira; Duvenhage, Michael; Winter, Jill; Song, Taeksun; Walzl, Gerhard; Diacon, Andreas H; Barry, Clifton E 3rd
发表日期：2021
文献求助 收藏

Optimizing β-Lactams against Tuberculosis

优化β-内酰胺类抗生素抗结核病

期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.201911-2149LE
de Jager, Veronique R; Vanker, Naadira; van der Merwe, Lize; van Brakel, Elana; Muliaditan, Morris; Diacon, Andreas H
发表日期：2020
文献求助 收藏

Reply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis

回复 Decroo 等人：复发性利福平敏感结核病的一线高剂量治疗方案

期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.202002-0359LE
Dooley, Kelly E; Miyahara, Sachiko; von Groote-Bidlingmaier, Florian; Sun, Xin; Hafner, Richard; Rosenkranz, Susan L; Ignatius, Elisa H; Nuermberger, Eric L; Moran, Laura; Donahue, Kathleen; Swindells, Susan; Vanker, Naadira; Diacon, Andreas H
发表日期：2020
文献求助 收藏

Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial

不同剂量异烟肼对耐药结核病的早期杀菌活性（INHindsight）：一项随机、开放标签临床试验

期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.201910-1960OC
Dooley, Kelly E; Miyahara, Sachiko; von Groote-Bidlingmaier, Florian; Sun, Xin; Hafner, Richard; Rosenkranz, Susan L; Ignatius, Elisa H; Nuermberger, Eric L; Moran, Laura; Donahue, Kathleen; Swindells, Susan; Vanker, Naadira; Diacon, Andreas H
发表日期：2020
文献求助 收藏

Reply to Kim et al., "Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment"

回复 Kim 等人，“最佳剂量还是最佳暴露量？利奈唑胺在结核病治疗中的应用考量”

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00709-20
Diacon, Andreas H; De Jager, Veronique R; Dawson, Rodney; Narunsky, Kim; Vanker, Naadira; Burger, Divan A; Everitt, Daniel; Pappas, Frances; Nedelman, Jerry; Mendel, Carl M
发表日期：2020
文献求助 收藏